Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite

• Status: Withdrawn
• Trial end date: 2007-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine wether the combination of Ramatroban/Montelukast is as effective as Montelukast alone in patients with mild to moderate atopic asthma (GINA I and II) sensitive to house dust mite. The test is performed by a specific inhalative provocation.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Research Center Borstel
• Treatments: Montelukast; Ramatroban

Criteria

Inclusion Criteria:

• Atopic (house dust mite) asthma

• Severity GINA one and two

Exclusion Criteria:

• No reaction in specific bronchial provocation test

• Other kind of clinical relevant atopic reaction